Relapse rate and predictors among people with severe mental illnesses at Debre Markos Comprehensive specialized hospital, Northwest Ethiopia: a prospective follow up study

IF 3.5 3区 医学 Q1 CLINICAL NEUROLOGY
Haile Amha, Asmamaw Getnet, Birhanu Mengist Munie, Tilahun Workie, Girma Alem, Henok Mulugeta, Keralem Anteneh Bishaw, Temesgen Ayenew, Mihretie Gedfew, Melaku Desta, Muluken Wubetu
{"title":"Relapse rate and predictors among people with severe mental illnesses at Debre Markos Comprehensive specialized hospital, Northwest Ethiopia: a prospective follow up study","authors":"Haile Amha, Asmamaw Getnet, Birhanu Mengist Munie, Tilahun Workie, Girma Alem, Henok Mulugeta, Keralem Anteneh Bishaw, Temesgen Ayenew, Mihretie Gedfew, Melaku Desta, Muluken Wubetu","doi":"10.1007/s00406-024-01900-1","DOIUrl":null,"url":null,"abstract":"<p>Severe mental illness is usually marked by periods of remission, when symptoms are absent or well controlled, and of exacerbation, when symptoms return or worsen. Relapse of these severe illnesses costs a lot for patients and their families and imposes a financial burden on hospital and community services. Costs for relapse cases were four times higher than that of non-relapse cases. There is a dearth of evidence in on relapse rate on these vulnerable population in Sub-Saharan Africa, therefore this study assessed relapse rate and predictors among people with severe mental illnesses at Debre Markos Comprehensive specialized hospital, Northwest Ethiopia. Prospective follow up study design was employed among 315 people with severe mental illnesses who were selected by systematic random sampling technique. Epi.data version 4.2 was used for data entry and exported to STATA 14 for analysis. The Kaplan-Meier curve was used to estimate the median duration of occurrence and the Log rank test was used to compare survival curves between different categories of explanatory variables. A survival analysis was used to estimate the cumulative rate of relapse, Cox proportional hazards models was used to examine independent factors associated with time to develop relapse. To estimate the association between predictors and relapse, hazard ratio with 95% confidence intervals was used. Variables score p value &lt; 0.25 with in the Bivariable analysis was entered in to the multivariable analysis model. The statistical significance was accepted at p-value &lt; 0.05. Around 119 (37.78%) had develop relapse, and the remaining 196 (62.22%) were censored. The overall incidence rate of relapse was 3.66 per 100 person-month (95% CI:3.06–4.38) with a total of 3250 patient-month observations. Variables such as: age (18–36 years) [(AHR) = 3.42:95% (CI) :1.67,6.97)], marital status (single and widowed) 1.87 [AHR: 1.87; 95% CI: (1.06 ,3.27)] and 2.14 [AHR: 2.14; 95% CI: (1.03 ,4.44)], duration of delay in getting treatment ( &gt; = 1 year) [(AHR = 2.55:CI:1.20, 5.38)], types of diagnosis (Major Depressive Disorder) (AHR = 2.38, CI:1.37 ,4.14), medication adherence (low adherence) (AHR = 5.252.45, 11.21) were statistically significant (P value &lt; 0.05). Nearly two-fifth of people diagnosis with severe mental illnesses had develop relapse and the median survival time to develop relapse was nine months. It is advised that early detection of severe mental illness and early initiation of treatments are very crucial to prevent relapse. Psycho education, counseling that alleviates poor treatment adherence are highly recommended.</p>","PeriodicalId":11822,"journal":{"name":"European Archives of Psychiatry and Clinical Neuroscience","volume":"15 1","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Archives of Psychiatry and Clinical Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00406-024-01900-1","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Severe mental illness is usually marked by periods of remission, when symptoms are absent or well controlled, and of exacerbation, when symptoms return or worsen. Relapse of these severe illnesses costs a lot for patients and their families and imposes a financial burden on hospital and community services. Costs for relapse cases were four times higher than that of non-relapse cases. There is a dearth of evidence in on relapse rate on these vulnerable population in Sub-Saharan Africa, therefore this study assessed relapse rate and predictors among people with severe mental illnesses at Debre Markos Comprehensive specialized hospital, Northwest Ethiopia. Prospective follow up study design was employed among 315 people with severe mental illnesses who were selected by systematic random sampling technique. Epi.data version 4.2 was used for data entry and exported to STATA 14 for analysis. The Kaplan-Meier curve was used to estimate the median duration of occurrence and the Log rank test was used to compare survival curves between different categories of explanatory variables. A survival analysis was used to estimate the cumulative rate of relapse, Cox proportional hazards models was used to examine independent factors associated with time to develop relapse. To estimate the association between predictors and relapse, hazard ratio with 95% confidence intervals was used. Variables score p value < 0.25 with in the Bivariable analysis was entered in to the multivariable analysis model. The statistical significance was accepted at p-value < 0.05. Around 119 (37.78%) had develop relapse, and the remaining 196 (62.22%) were censored. The overall incidence rate of relapse was 3.66 per 100 person-month (95% CI:3.06–4.38) with a total of 3250 patient-month observations. Variables such as: age (18–36 years) [(AHR) = 3.42:95% (CI) :1.67,6.97)], marital status (single and widowed) 1.87 [AHR: 1.87; 95% CI: (1.06 ,3.27)] and 2.14 [AHR: 2.14; 95% CI: (1.03 ,4.44)], duration of delay in getting treatment ( > = 1 year) [(AHR = 2.55:CI:1.20, 5.38)], types of diagnosis (Major Depressive Disorder) (AHR = 2.38, CI:1.37 ,4.14), medication adherence (low adherence) (AHR = 5.252.45, 11.21) were statistically significant (P value < 0.05). Nearly two-fifth of people diagnosis with severe mental illnesses had develop relapse and the median survival time to develop relapse was nine months. It is advised that early detection of severe mental illness and early initiation of treatments are very crucial to prevent relapse. Psycho education, counseling that alleviates poor treatment adherence are highly recommended.

Abstract Image

埃塞俄比亚西北部 Debre Markos 综合专科医院重症精神病患者的复发率和预测因素:一项前瞻性跟踪研究
重症精神病通常会有缓解期和加重期,缓解期是指症状消失或得到很好的控制,加重期 是指症状复发或加重。这些严重疾病的复发给患者及其家庭带来了巨大的损失,也给医院和社区服务带来了沉重的经济负担。复发病例的费用是非复发病例的四倍。在撒哈拉以南非洲地区,有关这些弱势人群复发率的证据十分匮乏,因此本研究评估了埃塞俄比亚西北部 Debre Markos 综合专科医院重症精神病患者的复发率和预测因素。本研究采用前瞻性跟踪研究设计,通过系统随机抽样技术选取了 315 名重症精神病患者。数据录入使用 Epi.data 4.2 版,并导出到 STATA 14 进行分析。采用 Kaplan-Meier 曲线估算发生时间的中位数,并用对数秩检验比较不同类别解释变量之间的生存曲线。生存分析用于估算复发的累积率,Cox 比例危险模型用于研究与复发时间相关的独立因素。为了估算预测因素与复发之间的关系,使用了带有 95% 置信区间的危险比。在二变量分析中得分 p 值为 0.25 的变量被纳入多变量分析模型。统计学意义以 p 值为 0.05。约 119 人(37.78%)复发,其余 196 人(62.22%)被剔除。复发的总发生率为每百人月 3.66 例(95% CI:3.06-4.38),共观察了 3250 个病人月。年龄(18-36 岁)[(AHR)= 3.42:95%(CI):1.67,6.97)]、婚姻状况(单身和丧偶)1.87 [AHR: 1.87; 95% CI: (1.06 ,3.27)]和 2.14 [AHR: 2.14; 95% CI: (1.03 ,4.44)]、延误治疗时间(> = 1 年)[(AHR = 2.55:CI:1.20,5.38)]、诊断类型(重度抑郁障碍)(AHR = 2.38,CI:1.37 ,4.14)、用药依从性(低依从性)(AHR = 5.252.45,11.21)均有统计学意义(P 值为 <0.05)。近五分之二的重症精神病患者复发,复发后的中位生存时间为 9 个月。建议尽早发现重性精神病并尽早开始治疗对防止复发至关重要。我们强烈建议开展心理教育和咨询,以缓解治疗依从性差的问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
8.80
自引率
4.30%
发文量
154
审稿时长
6-12 weeks
期刊介绍: The original papers published in the European Archives of Psychiatry and Clinical Neuroscience deal with all aspects of psychiatry and related clinical neuroscience. Clinical psychiatry, psychopathology, epidemiology as well as brain imaging, neuropathological, neurophysiological, neurochemical and moleculargenetic studies of psychiatric disorders are among the topics covered. Thus both the clinician and the neuroscientist are provided with a handy source of information on important scientific developments.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信